Cloud-Based Connectivity Platform Advances Decentralized Healthcare
|
By LabMedica International staff writers Posted on 03 Aug 2016 |
|
Image: Fionet connectivity with the Fio Deki Reader (Photo courtesy of Fio).
A novel reporting platform enables real-time oversight, fragile network connectivity, and actionable insights for medical device manufacturers and healthcare providers.
The Fio (Toronto, Canada) Fionet platform connects mobile companion devices that guide diagnosis, treatment, and record keeping with web-based tools for remote oversight and reporting. Fionet mobile software is designed for standard Android devices and the proprietary Deki Reader, a rugged, in vitro diagnostic (IVD) device for use with commercially available lateral flow immunoassays. As the Deki Reader provides step-by-step guidance for performing rapid diagnostic tests and delivers an objective analysis of results, Fionet provides test-by-test traceability.
As connectivity becomes an essential prerequisite for diagnostic platforms, Fionet meets the challenge by providing web-based tools for timely, accurate and complete record taking of individual patient visits; generating reports from aggregated, primary data; allowing two-way messaging with companion IVD devices; and easy data transfer and information technology (IT) integration. Fio will present the Fionet platform at AACC 2016.
“With healthcare services becoming more and more decentralized, device manufacturers are adapting their products from the lab outward. At Fio, we’ve built our data services from the field inward,” said Ian Fine, Chief Technology Officer of Fio. “Fio’s appearance at the AACC trade fair this year will provide an opportunity for the company to share insights from connecting diagnostics and data in developing countries.”
The American Association for Clinical Chemistry (AACC; Washington, DC, USA) is an international scientific/medical society of over 8,000 clinical laboratory professionals, physicians, research scientists and more. The AACC annual meeting, which will be held from July 31st to August 4th at the Pennsylvania Convention Center in Philadelphia (USA), features five days of educational sessions on scientific, clinical, technical and management challenges facing laboratory professionals, as well as the world’s largest Clinical Lab Expo.
Related Links:
Fio
American Association for Clinical Chemistry
.jpg)
The Fio (Toronto, Canada) Fionet platform connects mobile companion devices that guide diagnosis, treatment, and record keeping with web-based tools for remote oversight and reporting. Fionet mobile software is designed for standard Android devices and the proprietary Deki Reader, a rugged, in vitro diagnostic (IVD) device for use with commercially available lateral flow immunoassays. As the Deki Reader provides step-by-step guidance for performing rapid diagnostic tests and delivers an objective analysis of results, Fionet provides test-by-test traceability.
As connectivity becomes an essential prerequisite for diagnostic platforms, Fionet meets the challenge by providing web-based tools for timely, accurate and complete record taking of individual patient visits; generating reports from aggregated, primary data; allowing two-way messaging with companion IVD devices; and easy data transfer and information technology (IT) integration. Fio will present the Fionet platform at AACC 2016.
“With healthcare services becoming more and more decentralized, device manufacturers are adapting their products from the lab outward. At Fio, we’ve built our data services from the field inward,” said Ian Fine, Chief Technology Officer of Fio. “Fio’s appearance at the AACC trade fair this year will provide an opportunity for the company to share insights from connecting diagnostics and data in developing countries.”
The American Association for Clinical Chemistry (AACC; Washington, DC, USA) is an international scientific/medical society of over 8,000 clinical laboratory professionals, physicians, research scientists and more. The AACC annual meeting, which will be held from July 31st to August 4th at the Pennsylvania Convention Center in Philadelphia (USA), features five days of educational sessions on scientific, clinical, technical and management challenges facing laboratory professionals, as well as the world’s largest Clinical Lab Expo.
Related Links:
Fio
American Association for Clinical Chemistry
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Manual Pipetting Aid
Pipette Controllers macro
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Latest AACC 2016 News
- Molecular Test Detects Three Arboviruses in Plasma Samples
- Derived Exosomal Protein Biomarkers in Alzheimer’s Disease Diagnosis
- New Biochip Array Developed for ApoE4 Classification
- Cell-Free DNA Identifies Liver Transplant Patients with Acute Rejection
- New Method Tested for Early Diagnosis Pediatric Diabetic Nephropathy
- FDA-Cleared Automated Cell Counter for CSF Launched at AACC 2016
- Semen Analysis Portfolio with Two New Products Featured at AACC 2016
- Automation Solutions for Clinical Diagnostic Equipment Showcased at AACC 2016
- New Tubes Designed for Medium Sample Volumes
- Multi Sample Osmometer Improves Testing Efficiency
- Innovative Information System Optimizes Laboratory Processes
- Innovative eLearning Interface Seamlessly Connects Competency Data
- Adhesives Research to Present Hydrophilic Adhesive Technologies
- Point-of-Care Immunoassay Analyzer on Display at AACC Annual Meeting
- Assay for Determination of 17-OH Progesterone to Be Featured at AACC Annual Meeting
- Fully Automated HbA1c Analyzer Available for Inspection at AACC Annual Meeting
Channels
Clinical Chemistry
view channel
Blood Proteins Linked to Mortality Risk and Biological Aging Across Organ Systems
Older adults of the same chronological age can differ markedly in health, chronic disease burden, and resilience. Biological age aims to capture these differences by reflecting how rapidly the body and... Read more
Two-Step Blood Test Improves Specificity for Alzheimer’s Diagnosis
Early Alzheimer’s disease can be difficult to identify before more severe cognitive symptoms emerge. Blood tests measuring phosphorylated tau protein p-tau217 may help detect disease-related changes, but... Read more
Molecular Diagnostics
view channel
Tumor and Immune Biomarkers Linked to Treatment Response in T-Cell Lymphoma
T-follicular helper cell lymphoma (TFHL) is a subtype of peripheral T-cell lymphoma associated with poor prognosis and limited treatment options after relapse. Its molecular abnormalities include frequent... Read more
Blood MRD Testing Aids Risk Analysis in Bladder and Other Cancers
Natera (Austin, TX, USA) presented findings from 25 abstracts, including nine oral presentations, at the ESMO Congress 2026 in Madrid. The research examined circulating tumor DNA (ctDNA) testing for molecular... Read more
Hematology
view channel
Genetic Testing Offers Opportunities for Earlier Blood Disorder Carrier Identification
Inherited hemoglobin disorders can affect oxygen transport, yet individuals who carry only a trait may remain unaware of their status. People with sickle cell trait or beta-thalassemia trait often have... Read more
New Risk-Stratification Tool Predicts Relapse After Blinatumomab in Childhood ALL
Acute lymphoblastic leukemia in children and young people requires careful assessment of relapse risk, particularly as treatment approaches move beyond standard chemotherapy. Traditional relapse predictors... Read more
Immunology
view channel
Prototype Point-of-Care Lateral Flow Test Aims to Improve Neonatal Sepsis Triage
Sepsis in newborns and young infants remains a major clinical challenge, particularly in low- and middle-income countries. An estimated 2.3 million newborns die each year, with sepsis contributing substantially... Read more
Immune and Inflammatory Markers May Help Assess CAR T-Cell Complication Risk
Cytokine release syndrome (CRS) can occur after chimeric antigen receptor (CAR) T-cell therapy in patients with autoimmune disease. Identifying which patients are more likely to develop this complication... Read more
Microbiology
view channel
Decentralized Laboratory Network Improves Detection of Viral Hemorrhagic Fevers in Guinea
Viral hemorrhagic fevers remain a major diagnostic challenge in West Africa because their early symptoms can resemble those of other febrile illnesses. The 2014–2016 Ebola epidemic underscored the need... Read more
Molecular Panel Gains WHO Emergency Use Listing to Support Ebola Outbreak Response
The ongoing Ebola Bundibugyo outbreak in the Democratic Republic of the Congo and neighboring countries has become one of the largest outbreaks of this Ebola virus species recorded to date.... Read more
Pathology
view channel
AI Pathology Approach Closely Aligns With Breast Cancer Genomic Risk Classification
In early-stage breast cancer, precision oncology relies on biological information to guide personalized treatment decisions. Because access to tissue-based genomic testing may be limited, there is growing... Read more
Roche Launches Automated Test to Support Mesothelioma Differential Diagnosis
Mesothelioma is a rare, deadly cancer that forms in the tissue lining many internal organs. Most patients are diagnosed late, with median overall survival reported at 12 to 18 months. Differential diagnosis... Read more
Digital Pathology Test Stratifies Recurrence Risk in Early Breast Cancer
In hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer, accurate recurrence-risk assessment helps guide treatment decisions. However, individual risks... Read more
AI Pathology Tool Predicts DNA Repair Deficiency in High-Grade Serous Ovarian Cancer
High-grade serous tubo-ovarian carcinoma is an aggressive cancer arising in the ovaries or fallopian tubes. Some tumors exhibit homologous recombination deficiency (HRD), a feature reflecting impaired DNA repair.... Read moreTechnology
view channel
Microfluidic Assay Predicts Treatment Response in Pediatric Leukemia
Acute lymphoblastic leukemia (ALL) is a rapidly developing blood cancer that can disrupt production of mature infection-fighting white blood cells within months. More than 120,000 people in the U.... Read more
AI Models Use Routine Blood Tests and Health Records to Predict Cancer Risk
Cancer screening programs cover only certain cancers and often rely on broad eligibility criteria, limiting individualized risk assessment across multiple cancer types. Routine health data, including blood... Read more
Industry
view channel
CE-Marked IVD Sequencing Platform Launches Across Ten EU Countries
Clinical laboratories using sequencing in regulated diagnostic workflows need systems that support clearly defined processes and documentation. In Europe, meeting applicable EU IVDR requirements also means... Read more
